SEC 13F Intelligence

Greatmark Investment Partners, Inc. / ELV

Greatmark Investment Partners, Inc.’s Elevance Health Inc Formerly Position

Does Greatmark Investment Partners, Inc. own Elevance Health Inc Formerly (ELV)? Yes38.6K shares worth $11M (+1.32% of its 13F portfolio) as of Q1 2026, up from 36.8K shares the prior filed quarter.

Position Value
$11M
Q1 2026
Shares
38.6K
% of Portfolio
+1.32%
Quarters Held
30
currently held

Position History ELV

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $4MQ2 ’19: $4MQ3 ’19: $4MQ4 ’19: $6MQ4 ’19Q1 ’20: $4MQ2 ’20: $5MQ3 ’20: $5MQ4 ’20: $6MQ4 ’20Q1 ’21: $7MQ2 ’21: $7MQ3 ’21: $7MQ4 ’21: $9MQ4 ’21Q1 ’22: $9MQ2 ’22: $9MQ3 ’22: $8MQ4 ’22: $9MQ4 ’22Q1 ’23: $8MQ2 ’23: $8MQ3 ’23: $7MQ4 ’23: $9MQ4 ’23Q1 ’24: $10MQ2 ’24: $10MQ3 ’24: $10MQ4 ’24: $9MQ4 ’24Q1 ’25: $11MQ2 ’25: $11MQ3 ’25: $11MQ4 ’25: $13MQ4 ’25Q1 ’26: $11Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202638.6K$11M+1.32%
Q4 202536.8K$13M+1.52%
Q3 202535.5K$11M+1.37%
Q2 202528.6K$11M+1.40%
Q1 202526.1K$11M+1.55%
Q4 202423.9K$9M+1.20%
Q3 202419.3K$10M+1.36%
Q2 202419.1K$10M+1.51%
Q1 202418.8K$10M+1.39%
Q4 202318.5K$9M+1.37%
Q3 202317.1K$7M+1.31%
Q2 202317.0K$8M+1.27%
Q1 202317.4K$8M+1.42%
Q4 202217.4K$9M+1.63%
Q3 202217.8K$8M+1.56%
Q2 202217.8K$9M+1.65%
Q1 202218.4K$9M+1.49%
Q4 202118.5K$9M+1.44%
Q3 202118.6K$7M+1.30%
Q2 202118.8K$7M+1.30%
Q1 202119.3K$7M+1.35%
Q4 202019.8K$6M+1.37%
Q3 202019.8K$5M+1.34%
Q2 202018.9K$5M+1.31%
Q1 202019.2K$4M+1.40%
Q4 201918.6K$6M+1.39%
Q3 201917.1K$4M+1.12%
Q2 201914.9K$4M+1.25%
Q1 201914.7K$4M+1.33%
Q4 201815.1K$4M+1.43%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Greatmark Investment Partners, Inc.’s full portfolio or all institutional holders of ELV.